Active Broker’s Concerns In Focus: Canadian Solar (NASDAQ:CSIQ), Marathon Patent Group (NASDAQ:MARA)

Canadian Solar Inc. (NASDAQ:CSIQ) [Trend Analysis] knocking active thrust in leading trading session, shares a decrease of -1.10% to 12.56 with around 124157 shares have changed hands in this session. Canadian Solar Inc. (CSIQ) reported that its wholly owned subsidiary, Canadian Solar Solutions Inc., completed the sale of its 10 MW AC BeamLight LP and its 10 MW AC Alfred solar power plants to 9285806 Canada Inc. and Concord Beam Light GP2 Ltd., affiliates of Concord Green Energy Inc. for over CAD152.5 Million.

The transaction was closed on December 29, 2016 and the Company expects to recognize the difference between the sales proceeds and the book value of the projects under ‘Other income (expenses)’ in the income statement for the fourth quarter of 2016. BowMont Capital and Advisory acted as financial advisor to Concord on this transaction. The stock is going forward its fifty-two week low with 22.54% and lagging behind from its 52-week high price with -51.82%.

Similar, the positive performance for the quarter recorded as -14.42% and for the year was -44.76%, while the YTD performance remained at 4.27%. CSIQ has Average True Range for 14 days of 0.52.

Shares of Marathon Patent Group, Inc. (NASDAQ:MARA) [Trend Analysis] swings enthusiastically in regular trading session, it a decrease of -1.05% to close at $1.88. Marathon Patent Group, Inc. (NASDAQ: MARA) declared that on January 5, 2017, the Patent Trial and Appeal Board of the United States Patent and Trademark Office issued a ruling denying the IPR2016-01382 petition filed by Toyota Motor Corporation against U.S. Patent No. 5,732,375.

“We are pleased with the USPTO’s decisions denying Toyota’s IPR petition,” said Doug Croxall, CEO of Marathon Patent Group. “These rulings, along with those that have preceded it, continue to demonstrate the value of our proprietary process to assess, value, and acquire high quality patent assets that have the potential of generating meaningful return on investment for both the company and its shareholders.” Moving forward to saw long-term intention, the experts calculate Return on Investment of -49.10%. The stock is going forward its fifty-two week low with 45.74% and lagging behind from its 52-week high price with -45.35%. MARA last month stock price volatility remained 8.48%.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *